Evidence map›Paper›PMID 40302567›Full record

ArticleAcute and critical care2025

Characteristics and associated risk factors of exposure keratopathy among ventilated patients in intensive care units in Jordan

Sajeda Al-Tamimi, Mohammad Y N Saleh, Al-Mutez Gharaibeh, Farah Al-A'mar, Rasmieh Al-Amer

Abstract read
In one paragraph

Article in Acute and critical care, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sajeda Al-TamimiFaculty of Nursing, Arab Community College of Technology, Amman, Jordan.
Mohammad Y N SalehFaculty of Nursing, University of Jordan, Amman, Jordan.
Al-Mutez GharaibehDepartment of Ophthalmology, Faculty of Medicine, The University of Jordan, Amman, Jordan.
Farah Al-A'marFaculty of Nursing, Al-Zaytoonah University, Amman, Jordan.
Rasmieh Al-AmerFaculty of Nursing, Yarmouk University, Irbid, Jordan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Exposure keratopathy is the most common ocular surface disorder in ventilated patients due to poor eyelid closure, decreased blink reflex, and the inability to produce tears. Healthcare providers in intensive care units (ICUs) play a significant role in preventing exposure keratopathy through appropriate eyelid taping and eye ointments. Methods: This is a cross-sectional study to describe the characteristics and factors associated with exposure keratopathy in all mechanically ventilated patients admitted to an adult ICU between February and June 2023. Patients were examined for corneal changes using a corneal fluorescein staining test with a cobalt blue filter indirect ophthalmoscope. Results: Of 156 ventilated patients included in this study, 42.3% had exposure keratopathy, 13.5% had lagophthalmos, and 26.9% of patients had chemosis. For patients with a Glasgow Coma Scale (GCS) score of 3, the odds ratio of exposure keratopathy was 21.47 (95% confidence interval [CI], 2.82-163.05). The use of inotropes increased the odds ratio to 35.55 (95% CI, 3.41-369.90), whereas a hospital stay >7.23 days increased the odds ratio to 43.59 (95% CI, 15.66-1,316.32). Conclusions: The frequency of exposure keratopathy is high and is underestimated in ventilated patients, with lower GCS and increased hospital length of stay as the main risk factors. Prioritizing eye care in ventilated patients with low GCS scores or prolonged ICU stays is essential to reduce exposure keratopathy.

Indexed as

exposure keratopathyeye caresedationventilation

Identifiers

PMID40302567
PMCPMC12151726

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.